ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,847, issued on Sept. 16, was assigned to Children's Medical Center Corp. (Boston).
"ApoM-Fc fusion proteins for treating lung diseases" was invented by Timothy T. Hla (Wellesley, Mass.), Steven L. Swendeman (Cambridge, Mass.), Mark Puder (Medfield, Mass.) and Lois Smith (West Newton, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating lung disease using fusion proteins comprising ApoM (e.g., human or murine ApoM) fused to a constant region (Fc) of a immunoglobulin G (IgG, e.g., human IgG or murine IgG)."
The patent was filed on Oct. 11, 2019, under Application No. 17/284,299.
*For further information, incl...